RAFARM
RAFARM, officially known as RAFARM Group, is a prominent player in the pharmaceutical industry, headquartered in Greece (GR). Established in 1995, the company has made significant strides in the development and manufacturing of high-quality generic medicines and active pharmaceutical ingredients (APIs). With a strong operational presence across Europe and beyond, RAFARM is dedicated to enhancing healthcare through innovative solutions. The company’s core offerings include a diverse range of generic pharmaceuticals, which are distinguished by their rigorous quality standards and competitive pricing. RAFARM's commitment to research and development has positioned it as a trusted partner in the healthcare sector, earning recognition for its contributions to improving patient outcomes. With a focus on sustainability and compliance, RAFARM continues to solidify its market position as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does RAFARM's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RAFARM's score of 2 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RAFARM's reported carbon emissions
In 2023, RAFARM reported total carbon emissions of approximately 938,000 kg CO2e for Scope 1 and about 3,056,000 kg CO2e for Scope 2. This marks a slight increase in emissions from 2022, where Scope 1 emissions were about 888,000 kg CO2e and Scope 2 emissions were approximately 2,917,000 kg CO2e. RAFARM's emissions intensity for Scope 1 and Scope 2 combined is reported at 0.15 per production unit, while the annual electricity intensity for their premises stands at 0.29 per production unit. Despite these figures, there are currently no specific reduction targets or climate pledges disclosed by RAFARM, indicating a potential area for future commitment in their climate strategy. Overall, RAFARM's emissions data reflects their operational impact, and the absence of defined reduction initiatives suggests an opportunity for enhanced climate action moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 888,000 | 000,000 |
| Scope 2 | 2,917,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RAFARM is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
